Promus Capital, LLC Takeda Pharmaceutical CO LTD Put Options Transaction History
Promus Capital, LLC
- $106 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TAK
# of Institutions
333Shares Held
66.7MCall Options Held
1.99MPut Options Held
155K-
Capital Research Global Investors Los Angeles, CA13.2MShares$179 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.35MShares$72.9 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.63MShares$63 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.22MShares$57.4 Million0.05% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.41MShares$46.4 Million0.02% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $42.3B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...